From: The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease
 | Estimated number of new cases in 2011 (95% CrI) | DALY (95% CrI) | DALY per case (95% CrI) |
---|---|---|---|
Haemophilia (total) | 14 (7–22) | 145 (90–222) | 11 (8–15) |
 Severe | 6 (3–10) | 98 (43–175) | 17 (13–20) |
 Moderate | 3 (1–5) | 29 (27–31) | 12 (5–25) |
 Mild | 5 (2–8) | 18 (17–20) | 4 (2–9) |
Haemophilia A | 11 (5–18) | 123 (74–193) | 11 (8–16) |
 Severe | 5 (2–9) | 86 (37–156) | 17 (13–20) |
 Moderate | 2 (1–4) | 22 (20–23) | 12 (5–28) |
 Mild | 4 (2–7) | 15 (14–17) | 5 (2–10) |
Haemophilia B | 2 (1–5) | 22 (12–42) | 10 (5–18) |
 Severe | 1 (0–2) | 12 (2–32) | 17 (13–20) |
 Moderate | 1 (0–2) | 7 (6–8) | 16 (4–55) |
 Mild | 1 (0–2) | 3 (2–3) | 4 (1–13) |